Related Experiment Video
Updated: Jun 25, 2026

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
Published on: January 27, 2023
The heart and the liver
Søren Møller1, Christine Winkler Dümcke, Aleksander Krag
1Department of Clinical Physiology and Nuclear Medicine, 239, Hvidovre Hospital, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark. soeren.moeller@hvh.regionh.dk
Insights
Heart failure impacts liver function, potentially causing cardiac cirrhosis. Cirrhotic cardiomyopathy, a condition in advanced cirrhosis, impairs heart performance and requires treatment focused on the primary heart disease.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Cardiac failure and liver dysfunction are interconnected, with heart failure leading to conditions like cardiac cirrhosis and cardiogenic ischemic hepatitis.
- Advanced cirrhosis can manifest as cirrhotic cardiomyopathy, characterized by reduced cardiac performance, systolic/diastolic dysfunction, and electrophysiological abnormalities.
Purpose of the Study:
- To explore the intricate relationship between cardiac failure and liver dysfunction.
- To describe cirrhotic cardiomyopathy and its underlying pathophysiological mechanisms.
- To review the cardiac implications of interventions like transjugular intrahepatic portosystemic shunt insertion and liver transplantation in portal hypertensive patients.
Main Methods:
- Literature review of studies investigating the cardiac and hepatic interplay.
- Analysis of pathophysiological mechanisms in cirrhotic cardiomyopathy, including beta-adrenergic receptor signaling and electromechanical coupling.
- Examination of cardiac stress testing and imaging modalities for cirrhotic patients undergoing liver transplantation.
Main Results:
- Cardiac failure can cause liver damage, while liver cirrhosis can lead to cirrhotic cardiomyopathy with impaired cardiac function.
- Common findings in cirrhotic cardiomyopathy include systolic and diastolic dysfunction, electrophysiological abnormalities, and a prolonged QT interval.
- Procedures like transjugular intrahepatic portosystemic shunt insertion and liver transplantation pose risks to the cirrhotic heart, necessitating careful cardiac evaluation.
Conclusions:
- Treatment for cardiac dysfunction in liver disease should target the primary cardiac condition and ensure vital organ perfusion.
- While no specific therapy for cirrhotic cardiomyopathy exists, supportive care addressing heart failure is crucial.
- Thorough cardiac assessment, including stress testing and imaging, is vital for cirrhotic patients undergoing liver transplantation due to high perioperative risks.
Abstract:
Cardiac failure affects the liver and liver dysfunction affects the heart. Chronic and acute heart failure can lead to cardiac cirrhosis and cardiogenic ischemic hepatitis. These conditions may impair liver function and treatment should be directed towards the primary heart disease and seek to secure perfusion of vital organs. In patients with advanced cirrhosis, physical and/or pharmacological stress may reveal a reduced cardiac performance with systolic and diastolic dysfunction and electrophysical abnormalities, termed cirrhotic cardiomyopathy. Pathophysiological mechanisms include reduced beta-adrenergic receptor signal transduction and defective cardiac electromechanical coupling. However, the QT interval is prolonged in approximately half of patients with cirrhosis and it may be improved by beta-blockers. No specific therapy can be recommended but it should be supportive and directed against the heart failure. Transjugular intrahepatic portosystemic shunt insertion and liver transplantation affect cardiac function in portal hypertensive patients and cause stress to the cirrhotic heart, with a risk of perioperative heart failure. The risk and prevalence of coronary artery disease are increasing in cirrhotic patients and since perioperative mortality is high, careful evaluation of such patients with dobutamine stress echocardiography, coronary angiography and myocardial perfusion imaging is required prior to liver transplantation. Future research should focus on beneficial effects of treatment on cardiac function and mortality.
Related Concept Videos
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Overview of the Heart
The heart's structure...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Gross Anatomy of the Liver
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is covered...
Location and Orientation of the Heart
Chambers of the Heart
Deoxygenated blood from the body is received in the right...
